Sunday, April 19, 2015 9:13:54 AM
By Sue Thoms | on April 19, 2015 at 7:38 AM
Click For mlive.com Link
Dr. Dan Erck, left, and Brandon Hool train staff at the Red Project's Clean Works program in overdose reversals on Thursday, February 26, 2015. The program trains people in giving someone naloxone to reverse an overdose of heroin or other opiates and save a life. The program has trained more than 1,200 people since 2008 and has had close to 200 overdose reversals reported back to them. (Emily Rose Bennett | MLive.com)
Painkillers are causing great pain in our community.
From Heartside shelters to high-end homes in the suburbs, prescription drugs and heroin are leading to dependence, addiction, overdose and death.
MLive and The Grand Rapids will examine the deadly toll of opiates in West Michigan, the causes and the consequences. We would like to tell the stories of people affected by this growing public health crisis.
If you would like to share your story, please let us know. We are interested in hearing from people living in recovery, as well as the stories of loved ones lost to opioid drug abuse.
In the past 20 years, drug overdose deaths have quadrupled in Kent County. A similar picture is seen across Michigan and the U.S. In many areas, drug overdose is claiming more lives than car accidents.
In 2013, 37 percent of drug overdose deaths in the U.S. involved medications prescribed to treat pain, such as oxycodone, morphine and methadone. Addiction to painkillers is believed to fuel a growing market for heroin, a more potent and more deadly drug. Deaths related to heroin jumped 39 percent in just one year.
The federal government is undertaking a number of efforts to address this problem, such as updating prescription guidelines, promoting overdose reversal kits and expanding substance abuse treatment.
The statistics and the programs show only part of the picture, however. This is a human issue, one that affects individuals and families at a personal level.
In those individual stories, we see what is at stake as our community, state and nation grapple with this crisis.
If you are willing to talk to a reporter, please contact us. Send an email to grnews@mlive.com and let us know a few details of your story. Please include your name, age, where you live, and your contact information.
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Recent TTNP News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
- Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
- Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
- Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:41:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:45:22 PM
- Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:28:25 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM